We develop safe and efficacious drugs and powerful diagnostics with our proprietary Affimer® and pre|CISIONᵀᴹ platforms.
Avacta Group is a pioneering biotechnology research company dedicated to improving healthcare outcomes through the development of innovative targeted cancer treatments and advanced diagnostics. With a focus on creating safe and efficacious drugs, Avacta leverages its proprietary Affimer® and pre|CISIONᵀᴹ platforms to address critical needs in the healthcare sector.
Located in Wetherby, England at Thorp Arch Estate, LS23 7, GB with an additional location at Scale Space, White City in London, Avacta is committed to scientific excellence and innovation. The company’s dedication to cutting-edge research and development positions it as a key player in the biotechnology industry. Avacta continually strives to push the boundaries of what’s possible in healthcare, delivering solutions that make a meaningful difference in patients' lives.
Avacta is actively expanding its capabilities and welcomes you to discover the full potential of its groundbreaking technologies. We invite the management team to create a customized and exclusive company showcase and product listing on our platform, ensuring that Avacta's innovations reach a global audience.
Other organizations in the same industry
This company is also known as